Tokai reverse merges with Otic Pharma

15:40 EDT 11 Aug 2017 | Elsevier Business Intelligence

Following the Phase III failure of a lead cancer candidate, Tokai Pharmaceuticals Inc. agreed to a reverse merger with privat...

Original Article: Tokai reverse merges with Otic Pharma


More From BioPortfolio on "Tokai reverse merges with Otic Pharma"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...